Alar Pharmaceuticals Inc. (TPEX: 6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
154.50
+1.50 (0.98%)
Nov 21, 2024, 11:20 AM CST
-22.56%
Market Cap 10.12B
Revenue (ttm) 474.29M
Net Income (ttm) 400.72M
Shares Out 66.80M
EPS (ttm) 6.02
PE Ratio 25.18
Forward PE 263.48
Dividend 1.50 (0.98%)
Ex-Dividend Date Jun 5, 2024
Volume 58,297
Open 156.00
Previous Close 153.00
Day's Range 152.00 - 156.00
52-Week Range 143.00 - 465.00
Beta 0.07
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. It is developing ALA-1000, which is in Phase II clinical trials for the treatment of opioid use disorder; ALA-1300 and ALA-2000, which is in pre-clinical stage for opioid use disorder; ALA-4000 which is in pre-clinical stage for treatment of Parkinson’s disease; and ALA-3000, which is in pre-clinical stage for treating treatment-resistant depression. Alar Pharmaceuticals Inc. was founde... [Read more]

Sector Healthcare
Founded 2016
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.